INTENSIVE CARE OF SARS-COV-2 PATIENTS: OUR EXPERIENCE
DOI:
https://doi.org/10.31379/2411.2616.16.2.1Keywords:
coronavirus, intensive care, mechanical ventilation, extracorporeal methods.Abstract
We have analyzed 45-day experience of work in the COVID-hospital, based on a surgical center. Over 30% patients required mechanical ventilation (MV). The most severe patients over 80 years old (13,5%) and with BMI > 40 kg/m2 (21.8%). Russian Federation Healthcare Ministry guidelines were used during the treatment. 17,9% of patients were on non-invasive mechanical ventilation (NIMV), 33,9% – on high-flow nasal oxygen therapy (HFNOT). 69% were leaned from the MV, 19,8% of them leaned through tracheostomy. Hospital mortality rate was 4,8%. (female 55%, male 45%, obese patients – 36,8%, senile patients – 45% from all lethal cases). Effectiveness of consecutive use of different respiratory care methods, “fast track” methods during MV and extracorporeal methods of “cytokine storm” treatment had shown their effectiveness.
References
Clinical characteristics of coronavirus disease 2019 in China. / Guan W. J. та ін. N. Engl. J. Med. 2020.
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. / Huang C. та ін. Lancet. 2020. Вип. 395. Р. 497–506.
Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. / Liu Y. та ін. Sci. China Life Sci. 2020. Вип. 63. Р. 364–374.
Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19). Centers for Disease Control. https: //www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html Дата останнього входу: 12 вересня 2020 року.
Cytokine modulation in cardiac surgery: series of cases. / Shukevich D.L. та ін. Fundamental and clinical medicine. 2018. Т.3. №4. С. 51-59.
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients with Severe and Life-threatening COVID-19. Randomized Clinical Trial / Ling Li та ін. JAMA. 2020.
